Severe Hemophilia A Clinical Trials in Tianjin, Tianjin Municipality
2 recruitingTianjin, Tianjin Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.60 enrolled19 locationsNCT07684898
Recruiting
Phase 3
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.60 enrolled24 locationsNCT07663903